Suppr超能文献

不同预后系统和生物学标志物对预测急性胰腺炎严重程度及进展的价值。

Value of the different prognostic systems and biological markers for predicting severity and progression of acute pancreatitis.

作者信息

Dambrauskas Zilvinas, Gulbinas Antanas, Pundzius Juozas, Barauskas Giedrius

机构信息

Laboratory for Research of Digestive System, Institute for Biomedical Research, Kaunas University of Medicine, Kaunas, Lithuania.

出版信息

Scand J Gastroenterol. 2010 Aug;45(7-8):959-70. doi: 10.3109/00365521003770244.

Abstract

OBJECTIVE

Several tools have been developed for severity stratification in acute pancreatitis (AP). They include single biochemical markers and complex scoring systems, all of which aim at an early detection of severe AP to optimize monitoring and treatment of these patients. The aim of this study was to reassess and compare the value of some known and newly-introduced prognostic markers in the clinical context.

MATERIAL AND METHODS

We have conducted a prospective observational study. One hundred and eight patients with a diagnosis of AP and onset of the disease within last 72 h were included in this study. Clinical data and expression results of some serum biochemical markers were used for statistical analysis. The diagnostic performance of scores predicting severity and progression of AP, cut-off values, specificity, and sensitivity were established using receiver operating characteristic curve analysis.

RESULTS

Among single biochemical markers, C-reactive protein remains the most useful. Despite its delayed increase, it is accurate, cheap, and widely available. Interleukin-6 and macrophage migration inhibitory factor seem to be new promising parameters for use in clinical routine. Pancreas specific scores (Imrie-Glasgow, pancreatitis outcome prediction) and scores assessing organ dysfunction (acute physiology and chronic health evaluation II, multiple organ dysfunction score, and Marshall score) remain of value in determining the severity, complications, and possible outcome of AP.

CONCLUSIONS

Indication, timing, and consequences of the methods applied need to be carefully considered and incorporated into clinical assessments. Currently, there is no single prognostic marker that would cover the whole range of problems associated with the treatment of AP. The prediction of severity and progression of AP can be achieved using a series of accurate methods. The decision to undertake interventional or surgical treatment is the most complex task requiring both clinical judgment and meticulous monitoring of the patient.

摘要

目的

已开发出多种用于急性胰腺炎(AP)严重程度分层的工具。它们包括单一生化标志物和复杂评分系统,所有这些工具都旨在早期检测出重症AP,以优化对这些患者的监测和治疗。本研究的目的是在临床背景下重新评估和比较一些已知及新引入的预后标志物的价值。

材料与方法

我们进行了一项前瞻性观察研究。本研究纳入了108例诊断为AP且在过去72小时内发病的患者。临床数据以及一些血清生化标志物的表达结果用于统计分析。使用受试者工作特征曲线分析确定预测AP严重程度和进展的评分、临界值、特异性和敏感性的诊断性能。

结果

在单一生化标志物中,C反应蛋白仍然是最有用的。尽管其升高出现延迟,但它准确、廉价且广泛可用。白细胞介素-6和巨噬细胞移动抑制因子似乎是临床常规应用中有前景的新参数。胰腺特异性评分(Imrie-格拉斯哥评分、胰腺炎预后预测评分)以及评估器官功能障碍的评分(急性生理与慢性健康状况评分II、多器官功能障碍评分和马歇尔评分)在确定AP的严重程度、并发症及可能结局方面仍有价值。

结论

应用方法的适应证、时机和后果需要仔细考虑并纳入临床评估。目前,没有单一的预后标志物能涵盖与AP治疗相关的所有问题。使用一系列准确的方法可以实现对AP严重程度和进展的预测。决定进行介入或手术治疗是最复杂的任务,需要临床判断和对患者的细致监测。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验